224 related articles for article (PubMed ID: 34861900)
1. Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis.
Liauw J; Groom K; Ganzevoort W; Gluud C; McKinlay CJD; Sharp A; Mackay L; Kariya C; Lim K; von Dadelszen P; Limpens J; Jakobsen JC;
Syst Rev; 2021 Dec; 10(1):305. PubMed ID: 34861900
[TBL] [Abstract][Full Text] [Related]
2. STRIDER: Sildenafil Therapy In Dismal prognosis Early-onset intrauterine growth Restriction--a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis.
Ganzevoort W; Alfirevic Z; von Dadelszen P; Kenny L; Papageorghiou A; van Wassenaer-Leemhuis A; Gluud C; Mol BW; Baker PN
Syst Rev; 2014 Mar; 3():23. PubMed ID: 24618418
[TBL] [Abstract][Full Text] [Related]
3. STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials.
Pels A; Kenny LC; Alfirevic Z; Baker PN; von Dadelszen P; Gluud C; Kariya CT; Mol BW; Papageorghiou AT; van Wassenaer-Leemhuis AG; Ganzevoort W; Groom KM;
BMC Pregnancy Childbirth; 2017 Dec; 17(1):440. PubMed ID: 29282009
[TBL] [Abstract][Full Text] [Related]
4. Detailed statistical analysis plan for the Dutch STRIDER (Sildenafil TheRapy In Dismal prognosis Early-onset fetal growth Restriction) randomised clinical trial on sildenafil versus placebo for pregnant women with severe early onset fetal growth restriction.
Pels A; Jakobsen JC; Ganzevoort W; Naaktgeboren CA; Onland W; van Wassenaer-Leemhuis AG; Gluud C
Trials; 2019 Jan; 20(1):42. PubMed ID: 30635020
[TBL] [Abstract][Full Text] [Related]
5. STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction.
Groom KM; McCowan LM; Mackay LK; Lee AC; Gardener G; Unterscheider J; Sekar R; Dickinson JE; Muller P; Reid RA; Watson D; Welsh A; Marlow J; Walker SP; Hyett J; Morris J; Stone PR; Baker PN
BJOG; 2019 Jul; 126(8):997-1006. PubMed ID: 30779295
[TBL] [Abstract][Full Text] [Related]
6. Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial.
Pels A; Derks J; Elvan-Taspinar A; van Drongelen J; de Boer M; Duvekot H; van Laar J; van Eyck J; Al-Nasiry S; Sueters M; Post M; Onland W; van Wassenaer-Leemhuis A; Naaktgeboren C; Jakobsen JC; Gluud C; Duijnhoven RG; Lely T; Gordijn S; Ganzevoort W;
JAMA Netw Open; 2020 Jun; 3(6):e205323. PubMed ID: 32585017
[TBL] [Abstract][Full Text] [Related]
7. The ability of late pregnancy maternal tests to predict adverse pregnancy outcomes associated with placental dysfunction (specifically fetal growth restriction and pre-eclampsia): a protocol for a systematic review and meta-analysis of prognostic accuracy studies.
Griffin M; Heazell AEP; Chappell LC; Zhao J; Lawlor DA
Syst Rev; 2020 Apr; 9(1):78. PubMed ID: 32268905
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase-5 inhibitors in pregnancy: Systematic review and meta-analysis of maternal and perinatal safety and clinical outcomes.
Turner JM; Russo F; Deprest J; Mol BW; Kumar S
BJOG; 2022 Oct; 129(11):1817-1831. PubMed ID: 35352868
[TBL] [Abstract][Full Text] [Related]
9. Effect of L-arginine and sildenafil citrate on intrauterine growth restriction fetuses: a meta-analysis.
Chen J; Gong X; Chen P; Luo K; Zhang X
BMC Pregnancy Childbirth; 2016 Aug; 16():225. PubMed ID: 27528012
[TBL] [Abstract][Full Text] [Related]
10. Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial.
Sharp A; Cornforth C; Jackson R; Harrold J; Turner MA; Kenny LC; Baker PN; Johnstone ED; Khalil A; von Dadelszen P; Papageorghiou AT; Alfirevic Z;
Lancet Child Adolesc Health; 2018 Feb; 2(2):93-102. PubMed ID: 30169244
[TBL] [Abstract][Full Text] [Related]
11. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
Groom KM; David AL
Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
[TBL] [Abstract][Full Text] [Related]
12. Use of biochemical tests of placental function for improving pregnancy outcome.
Heazell AE; Whitworth M; Duley L; Thornton JG
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011202. PubMed ID: 26602956
[TBL] [Abstract][Full Text] [Related]
13. Halting the Canadian STRIDER randomised controlled trial of sildenafil for severe, early-onset fetal growth restriction: ethical, methodological, and pragmatic considerations.
von Dadelszen P; Audibert F; Bujold E; Bone JN; Sandhu A; Li J; Kariya C; Chung Y; Lee T; Au K; Skoll MA; Vidler M; Magee LA; Piedboeuf B; Baker PN; Lalji S; Lim KI
BMC Res Notes; 2022 Jul; 15(1):244. PubMed ID: 35799272
[TBL] [Abstract][Full Text] [Related]
14. The effects of sildenafil citrate on intrauterine growth restriction: a systematic review and meta-analysis.
Rakhanova Y; Almawi WY; Aimagambetova G; Riethmacher D
BMC Pregnancy Childbirth; 2023 Jun; 23(1):409. PubMed ID: 37268873
[TBL] [Abstract][Full Text] [Related]
15. Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early-onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo-controlled double-blind trial.
Khalil A; Sharp A; Cornforth C; Jackson R; Mousa H; Stock S; Harrold J; Turner MA; Kenny LC; Baker PN; Johnstone ED; Von Dadelszen P; Magee L; Papageorghiou AT; Alfirevic Z
Ultrasound Obstet Gynecol; 2020 Feb; 55(2):198-209. PubMed ID: 31432556
[TBL] [Abstract][Full Text] [Related]
16. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet agents for preventing pre-eclampsia and its complications.
Duley L; Meher S; Hunter KE; Seidler AL; Askie LM
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684684
[TBL] [Abstract][Full Text] [Related]
18. Planned early delivery versus expectant management of the term suspected compromised baby for improving outcomes.
Bond DM; Gordon A; Hyett J; de Vries B; Carberry AE; Morris J
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009433. PubMed ID: 26599471
[TBL] [Abstract][Full Text] [Related]
19. Melatonin for sleep disorders in children with neurodevelopmental disorders: protocol for a systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials.
Jørgensen CK; Hermann R; Juul S; Faltermeier P; Horowitz M; Moncrieff J; Gluud C; Jakobsen JC
BMJ Open; 2022 Nov; 12(11):e065520. PubMed ID: 36446459
[TBL] [Abstract][Full Text] [Related]
20. The clinical effects of cerebral near-infrared spectroscopy monitoring (NIRS) versus no monitoring: a protocol for a systematic review with meta-analysis and trial sequential analysis.
Hansen ML; Hyttel-Sørensen S; Jakobsen JC; Gluud C; Kooi EMW; Mintzer J; de Boode WP; Fumagalli M; Alarcon A; Alderliesten T; Greisen G
Syst Rev; 2021 Apr; 10(1):111. PubMed ID: 33863369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
